Hypoxia and Hemodilution Testing in Healthy Adult Volunteers

Part of paid clinical trials in San Francisco, California.

Sponsor
Nihon Kohden
Study ID
NCT07503171
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Hemodilution
  • Hypoxia

Eligibility Criteria

Sex
ALL
Age
18 Years - 35 Years
Healthy Volunteers
Accepted

Interventions

  • Noninvasive Physiological Monitoring Device — DEVICE
    Octopal R Noninvasive Pulse Wave Measuring Device DMO-8000X with TL 811S Finger Probe

Study Details

This study will collect physiological measurements in healthy adult volunteers under controlled hypoxia and hemodilution conditions.

Key Dates

Start date
Apr 2, 2026
Status verified
Mar 2026
Primary completion
Feb 1, 2027
Completion
Jan 31, 2028

Study Design

Enrollment
7 participants (estimated)

Arms

  • Arm: Adult healthy subjects
    Adult healthy subjects capable of undergoing controlled hypoxemia and hemodilution procedures.

Primary Outcome Measure

Collection of Hemoglobin and Oxygen Saturation Measurements [ Time Frame: From enrollment to the end of treatment up to 8 hours ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Vital Sign Research GroupSan FranciscoCalifornia94107
Greg Stratmann, MD, PhD
[email protected]
(650) 868-5155

Find similar trials in San Francisco, CA

By research site
Vital Sign Research Group· San Francisco, CA

Related Studies